515 related articles for article (PubMed ID: 1710066)
41. Ultrasound detection of placental insufficiency in women with elevated second trimester serum alpha-fetoprotein or human chorionic gonadotropin.
Toal M; Chaddha V; Windrim R; Kingdom J
J Obstet Gynaecol Can; 2008 Mar; 30(3):198-206. PubMed ID: 18364097
[TBL] [Abstract][Full Text] [Related]
42. Screening of maternal serum for fetal Down's syndrome in the first trimester.
Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A
N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983
[TBL] [Abstract][Full Text] [Related]
43. A transcervical amniotic fluid collector: a new medical device for the assessment of amniotic fluid in patients with ruptured membranes.
Lee SM; Romero R; Park JS; Chaemsaithong P; Jun JK; Yoon BH
J Perinat Med; 2015 Jul; 43(4):381-9. PubMed ID: 25372723
[TBL] [Abstract][Full Text] [Related]
44. Comparison and integration of first trimester fetal nuchal translucency and second trimester maternal serum screening for fetal Down syndrome.
Lam YH; Lee CP; Sin SY; Tang R; Wong HS; Wong SF; Fong DY; Tang MH; Woo HH
Prenat Diagn; 2002 Aug; 22(8):730-5. PubMed ID: 12210586
[TBL] [Abstract][Full Text] [Related]
45. Risk assessment of amniocentesis between 11 and 15 weeks: comparison to later amniocentesis controls.
Crandall BF; Kulch P; Tabsh K
Prenat Diagn; 1994 Oct; 14(10):913-9. PubMed ID: 7534922
[TBL] [Abstract][Full Text] [Related]
46. Changes in alpha-fetoprotein levels in a case with multiple congenital anomalies.
Lau HL; Heller RH; Goscin S; Winn K; Linkins SE
Am J Obstet Gynecol; 1977 May; 128(2):225-6. PubMed ID: 67807
[TBL] [Abstract][Full Text] [Related]
47. Mid-trimester maternal serum AFP and hCG as markers of preterm and term adverse pregnancy outcomes.
Tancrède S; Bujold E; Giguère Y; Renald MH; Girouard J; Forest JC
J Obstet Gynaecol Can; 2015 Feb; 37(2):111-6. PubMed ID: 25767942
[TBL] [Abstract][Full Text] [Related]
48. Amniocentesis. The experience in a district hospital.
Ogueh O; Baffour M; Hibbert K; McMillan L
Clin Exp Obstet Gynecol; 1996; 23(3):133-5. PubMed ID: 8894318
[TBL] [Abstract][Full Text] [Related]
49. Amniotic fluid alpha-fetoprotein determination at the time of genetic amniocentesis: has it outlived its usefulness?
Shields LE; Uhrich SB; Komarniski CA; Wener MH; Winter TC
J Ultrasound Med; 1996 Nov; 15(11):735-9. PubMed ID: 8908583
[TBL] [Abstract][Full Text] [Related]
50. Amniotic fluid concentrations of alpha-fetoprotein (AFP) in early normal pregnancy, and pregnancy complicated by neural tube defects. A review of 18 months experience.
Coltart RM; Seller MJ; Singer JD; Campbell S
Guys Hosp Rep; 1974; 123(2):121-9. PubMed ID: 4143202
[TBL] [Abstract][Full Text] [Related]
51. Alteration in age-specific risks for chromosomal trisomy by maternal serum alpha-fetoprotein and human chorionic gonadotropin screening.
Miller CH; O'Brien TJ; Chatelain S; Butler BB; Quirk JG
Prenat Diagn; 1991 Mar; 11(3):153-8. PubMed ID: 1710067
[TBL] [Abstract][Full Text] [Related]
52. Origin of raised maternal serum alpha-fetoprotein levels in second-trimester oligohydramnios.
Los FJ; Beekhuis JR; Marrink J; Hagenaars AM; Reuss A; Sachs ES; Jahoda MG; Wladimiroff JW
Prenat Diagn; 1992 Jan; 12(1):39-45. PubMed ID: 1372972
[TBL] [Abstract][Full Text] [Related]
53. Decreased alpha-fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy.
Henriques CU; Damm P; Tabor A; Pedersen JF; Mølsted-Pedersen L
Obstet Gynecol; 1993 Dec; 82(6):960-4. PubMed ID: 7694215
[TBL] [Abstract][Full Text] [Related]
54. The relationship between maternal serum and amniotic fluid alpha-fetoprotein in women undergoing early amniocentesis.
Brumfield CG; Cloud GA; Davis RO; Finley SC; Hauth JC; Boots L
Am J Obstet Gynecol; 1990 Sep; 163(3):903-6. PubMed ID: 1698336
[TBL] [Abstract][Full Text] [Related]
55. Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol.
Extermann P; Bischof P; Marguerat P; Mermillod B
Hum Reprod; 1998 Jan; 13(1):220-3. PubMed ID: 9512261
[TBL] [Abstract][Full Text] [Related]
56. First-trimester maternal serum biochemical indicators in Down syndrome.
Brock DJ; Barron L; Holloway S; Liston WA; Hillier SG; Seppala M
Prenat Diagn; 1990 Apr; 10(4):245-51. PubMed ID: 1694994
[TBL] [Abstract][Full Text] [Related]
57. Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha-fetoprotein, and age.
Crossley JA; Aitken DA; Connor JM
Prenat Diagn; 1991 Feb; 11(2):83-101. PubMed ID: 1712100
[TBL] [Abstract][Full Text] [Related]
58. Effect of predilatation of the uterine cervix by laminaria tent on activity of the placenta.
Jonasson A; Pschera H; Carlström K
Acta Obstet Gynecol Scand; 1992 Jan; 71(1):46-7. PubMed ID: 1315097
[TBL] [Abstract][Full Text] [Related]
59. SURUSS in perspective.
Wald NJ; Rodeck C; Hackshaw AK; Rudnicka A
Semin Perinatol; 2005 Aug; 29(4):225-35. PubMed ID: 16104673
[TBL] [Abstract][Full Text] [Related]
60. The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome.
Spencer K; Crossley JA; Aitken DA; Nix AB; Dunstan FD; Williams K
Ann Clin Biochem; 2003 May; 40(Pt 3):219-31. PubMed ID: 12803832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
